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Cachexia is a terminal metabolic problem observed in a wide variety of tumours. In this article I propose 
that the syndrome is a direct consequence of the common feature to all malignant tumours: growth. I sug- 
gest that the requirement for essential amino acids can be used as the unifying principle that links the tumour 
to the two main components of cachexia: muscle wastage and anorexia. This underlying factor is usually 
clouded by the overlapping of individual tumour characteristics. 
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1. INTRODUCTION 
Cachexia is the most common general metabolic 
syndrome and cause of death in cancer patients but 
its pathogenesis i  still a matter of controversy [l]. 
The syndrome is observed in a wide variety of 
tumours, so to understand it one approach would 
be to look for what they share, like growth, rather 
than their differences. ,What are the metabolic 
characteristics of an actively growing cell? What is 
the physiological response of the organism to a 
local growth demand? Is that response normal or 
pathological? 
The particular demands of a tumour depend on 
the fraction of cells growing and their growth rate 
[2]. The tumour cells have an enzymatic phenotype 
similar to that of embryos [3]; both are growing 
populations. The tumour cell population has to be 
viewed within the cell community that constitutes 
the organism. In this context there are several 
points that are needed to understand the metabolic 
interaction of different cell populations: 
Existence of individual metabolic phenotypes, 
e.g., growth. 
Existence of localization of specific functions 
that are performed by an organ for the benefit of 
the whole organism, e.g., gluconeogenesis n liver. 
Cells are continuously fed from the organism 
stores. Stores are replenished in a non-continuous 
fashion by exogenous ingestion. 
The flow of nutrients between different pools of 
the organism, separated by membranes, is affected 
by concentrations and ratios of nutrients at both 
sides of the membranes. 
2. AMINO ACID POOLS 
In order to study the effect of tumourigenesis on 
amino acid metabolism we must first determine 
what different compartments are involved. There 
are two types of amino acid pools: a fast reacting 
pool formed by free amino acids of intracellular 
and extracellular locations, their main reservoir be- 
ing the muscle. The second type, a slow reacting 
pool, is formed by proteins, which is mainly an in- 
tracellular pool with skeletal muscle as its main 
component. The interconversion between the two 
pools takes place intracellularly [4]. The fast reac- 
ting pool is characterized by its high mobility and 
changes due to the exogenous supply by diet or 
utilization by individual groups of cells. Between 
the muscle reservoir and the rest of intracellular in- 
dividual pools is the plasma pool, small in size but 
at the center of all daily fluctuations in the 
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organism, working as a bridge pool among dif- 
ferent cell populations. A diagram of these pools 
and the flux among them in a cancer patient is 
shown in fig. 1. For growing cells there is a one-way 
flux since the cells are taking up amino acids; in 
contrast the reservoir organ, muscle, has a two- 
way flux, storage and maintenance of supply to 
other cells, so there is a localization of storage and 
utilization of amino acids. 
Between these different free pools there is a 
membrane barrier with several transport systems 
each of them involved in the translocation of a par- 
ticular group of amino acids; these transport 
systems can operate in both directions and have 
particular properties [5,6] but their function in the 
presence of several amino acids using the same car- 
rier system from both sides of the membrane is not 
yet known. So far transport regulation is poorly 
understood in this context, but is of vital impor- 
tance for the understanding of interorgan nutrition 
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Fig. 1. Flux of essential amino acids among different 
pools in an adult cancer patient. 
3. TUMOUR EFFECTS ON AMINO ACID 
METABOLISM 
The growing tumour is making a demand on 
nutrients required, e.g., essential amino acids. The 
tumour growth will deplete its essential in- 
tracellular amino acid pool, unless there is an ex- 
tracellular source (plasma) but for growth it is im- 
portant to keep the internal amino acid concentra- 
tion at an adequate level, so the free intracellular 
pool connected with the extracellular one creates a 
downward gradient towards the inside of the 
tumoural cell (fig.1); it is important to note that 
the transport system for leucine works better in 
that way [5]. The plasma pool can be depleted in 
a short time because of its small size, a 300 g 
tumour can do it in less than 1 day, but before this 
happens the muscle free amino acid pool will re- 
spond to the extracellular changes no matter what 
the origin of the demand, since the muscle does not 
discriminate but just senses a demand. This 
response would be a release of amino acids from 
the muscle free intracellular pool and this would be 
reflected in muscle metabolism, first as a decrease 
in its ability to synthesize protein [7,8], resulting in 
net loss without increasing degradation, at later 
stages degradation will also increase [19]. This 
reaction might initially be observed as a negative 
nitrogen balance. Muscle studies in patients con- 
firm these predictions [7,8]. The demand for essen- 
tial amino acids has been observed in cancer pa- 
tients [9]. But while essential amino acids have a 
destination, non-essential amino acids mobilized at 
the same time contribute to the host metabolic pic- 
ture, e.g., altered amino ‘acid ratios, negative 
nitrogen balance and satiety [lo]. 
4. LEUCINE STARVATION 
Leucine is probably the most studied amino acid 
in tumours. We can make a model situation by 
studying the effect of the tumour needs on the 
daily leucine requirement [111. As a tumour value, 
I have used 30 nmol/min per g cells, based on the 
total utilization of leucine [12]. This value cor- 
relates well with individual aspects of leucine 
metabolism studied in patients [9]. The tumour can 
increase considerably the daily need of leucine 
(fig.2). This increase has a better correlation with 
the clinical deterioration of the patient 121 than the 
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Fig.2. Effect of tumour growth on the daily requirements for energy and leucine recommended by FAO/WHO [ll] 
for a standard individual. Inset shows expanded the beginning of the clinical phase. The rates for glucose utilization 
and lactate production as well as overall leucine utilization are based on data from experimental animal [ 121. Tumour 
size represents that of the actively growing population, that is likely to be a fraction of the total tumour population. 
modification of carbohydrate and energy 
metabolism. Other essential amino acids are likely 
to follow a similar pattern but no study is available 
either in humans or experimental animals. This de- 
mand will create an amino acid flux towards the 
tumour. 
5. AMINO ACID METABOLISM IN CANCER 
PATIENTS 
The study of several parameters of protein 
metabolism in cancer patients shows a 33% in- 
crease in whole-body protein turnover with respect 
to non-cancer patients and starved non-cancer sub- 
jects [13]. The most striking feature is that the 
ratio of protein catabolism to protein synthesis is 
the same in both groups (fig.3) and independent of 
the nitrogen balance, suggesting that the coor- 
dinated regulation of both processes is maintained 
in the cancer patients [ 141. This observation is con- 
sistent with the amino acid pool response where 
regulation is indispensable. 
Similar alterations of protein metabolism have 
been reported in other situations, e.g., healing 
after surgery and trauma [15-171. In all of them 
there is a locally growing cell population sug- 
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Fig.3. Correlation between protein catabolism and 
protein synthesis in cancer and non-cancer patients [13]. 
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gesting that the metabolic alteration is more likely 
to be the organism response to a local demand than 
tumour specific. If there is a growing cell popula- 
tion competing for nutrients with the tumour, 
cachexia will not be observed. This is the case of 
tumours in children [ 181. 
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